Zobrazeno 1 - 10
of 134
pro vyhledávání: '"John L. Wagner"'
Autor:
Dolores Grosso, Benjamin Leiby, Matthew Carabasi, Joanne Filicko-O'Hara, Sameh Gaballa, William O'Hara, John L. Wagner, Neal Flomenberg
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Specific major histocompatibility (MHC) class I alleles dominate anti-CMV responses in a hierarchal manner. These CMV immunodominant (IMD) alleles are associated with a higher magnitude and frequency of cytotoxic lymphocyte responses as compared to o
Externí odkaz:
https://doaj.org/article/259f4600aa3b4500b50ebcee8c7df933
Autor:
Michael Boyiadzis, Mei-Jie Zhang, Karen Chen, Hisham Abdel-Azim, Muhammad Bilal Abid, Mahmoud Aljurf, Ulrike Bacher, Talha Badar, Sherif M. Badawy, Minoo Battiwalla, Nelli Bejanyan, Vijaya Raj Bhatt, Valerie I. Brown, Paul Castillo, Jan Cerny, Edward A. Copelan, Charles Craddock, Bhagirathbhai Dholaria, Miguel Angel Diaz Perez, Christen L. Ebens, Robert Peter Gale, Siddhartha Ganguly, Lohith Gowda, Michael R. Grunwald, Shahrukh Hashmi, Gerhard C. Hildebrandt, Madiha Iqbal, Omer Jamy, Mohamed A. Kharfan-Dabaja, Nandita Khera, Hillard M. Lazarus, Richard Lin, Dipenkumar Modi, Sunita Nathan, Taiga Nishihori, Sagar S. Patel, Attaphol Pawarode, Wael Saber, Akshay Sharma, Melhem Solh, John L. Wagner, Trent Wang, Kirsten M. Williams, Lena E. Winestone, Baldeep Wirk, Amer Zeidan, Christopher S. Hourigan, Mark Litzow, Partow Kebriaei, Marcos de Lima, Kristin Page, Daniel J. Weisdorf
Publikováno v:
Leukemia. 37:1006-1017
Autor:
Xia Bi, Usama Gergis, John L. Wagner, Matthew Carabasi, Joanne Filicko-O’Hara, William O’Hara, Thomas Klumpp, Pierluigi Porcu, Neal Flomenberg, Dolores Grosso
Publikováno v:
Bone Marrow Transplantation. 57:1671-1680
Allogeneic hematopoietic stem cell transplantation (allo-SCT) remains the best curative option for the majority of patients with hematologic malignancies (HM); however, many elderly patients are excluded from transplant and outcome data in this popul
Autor:
Dolores Grosso, Benjamin Leiby, Lindsay Wilde, Matthew Carabasi, Joanne Filicko-O'Hara, William O'Hara, John L. Wagner, Gina Mateja, Onder Alpdogan, Adam Binder, Margaret Kasner, Gina Keiffer, Thomas Klumpp, Ubaldo Outschoorn Martinez, Neil Palmisiano, Pierluigi Porcu, Usama Gergis, Neal Flomenberg
Publikováno v:
Transplantation and cellular therapy. 28(12)
Contemporary, prospective data regarding the impact of granulocyte-colony stimulating factor (G-CSF) on outcomes after autologous hematopoietic stem cell transplantation (Auto-HSCT) in an era when stem cell grafts are more qualitatively robust are li
Autor:
Sushil Ghimire, Joanne Filicko-O'Hara, S. Onder Alpdogan, John L. Wagner, Matthew Carabasi, Sameh Gaballa, Michael Ramirez, Mark Weiss, Andrew E. Chapman, Jerald Z. Gong, Pierluigi Porcu, Jonathan Pan, Barbara Pro, Lewis J. Rose, Martina DiMeglio, Ubaldo E. Martinez-Outschoorn, Neal Flomenberg
Publikováno v:
Leukemia & Lymphoma. 62:590-597
We developed an outpatient salvage chemotherapy regimen using bendamustine, ofatumumab, carboplatin and etoposide (BOCE) to treat relapsed/refractory non-Hodgkin lymphoma (RR NHL) in a single-center phase I/II study. Primary objectives were safety, t
Autor:
Pierluigi Porcu, Neil Palmisiano, Dolores Grosso, Joanne Filicko-O'Hara, Thomas R. Klumpp, Ubaldo E. Martinez-Outschoorn, John L. Wagner, Matthew Carabasi, Usama Gergis, Shannon Rudolph, Maria Werner-Wasik, Neal Flomenberg, William O'Hara, Margaret Kasner, Lindsay Wilde, Wenyin Shi, Beth W. Colombe, Adam F. Binder, Michael Sun, Onder Alpdogan
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:1861-1867
The use of cyclophosphamide (CY) for bidirectional tolerization of recipient and donor T cells is associated with reduced rates of graft-versus-host disease (GVHD) and nonrelapse mortality (NRM) after HLA-matched hematopoietic stem cell transplantati
Autor:
Siddhartha Ganguly, Andrew Daly, Tracey A. O'Brien, Melhem Solh, Steven Z. Pavletic, Rammurti T. Kamble, Leslie Lehmann, Tao Wang, Takanori Teshima, Amer Beitinjaneh, Miguel Pérez, Mahmoud Aljurf, Mukta Arora, John L. Wagner, Medhat Askar, Marjolein van der Poel, Madan Jagasia, Rabi Hanna, Alvaro Urbano-Ispizua, Ravi Vij, Armin Rashidi, Taiga Nishihori, Catherine J. Lee, A. Samer Al-Homsi, Vijaya Raj Bhatt, Michael T. Hemmer, Roger Strair, Hannah Choe, Joseph Pidala, Jeffery J. Auletta, Hisham Abdel-Azim, Vaibhav Agrawal, Shahinaz M. Gadalla, Stefan O. Ciurea, S Spellman, Margaret L. MacMillan, Rodrigo Martino, Jean-Yves Cahn, Mitchell S. Cairo, Basem M. William, Rizwan Romee, Jean A. Yared, Navneet S. Majhail, Annie Im, Usama Gergis, Mohamed A. Kharfan-Dabaja, Richard F. Olsson, Sagar S. Patel, Baldeep Wirk, Peiman Hematti, Michael Byrne, Asad Bashey, Hemant S. Murthy, Betty K. Hamilton, Muna Qayed, Pooja Khandelwal, Robert Peter Gale, Saurabh Chhabra, Gerhard C. Hildebrandt, Jan Cerny, Sachiko Seo, Roger H. Herzig, Nosha Farhadfar, Deepesh Lad, Hélène Schoemans, Akshay Sharma, Tim Prestidge, Lazaros J. Lekakis, Daniel J. Weisdorf, Paul Castillo, Miguel-Angel Perales
Publikováno v:
Biol Blood Marrow Transplant
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Biology of Blood and Marrow Transplantation, 26(8), 1459-1468. Elsevier Science
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Biology of Blood and Marrow Transplantation, 26(8), 1459-1468. Elsevier Science
Post-transplant cyclophosphamide (PTCy) has significantly increased the successful use of haploidentical donors with a relatively low incidence of graft-versus-host disease (GVHD). Given its increasing use, we sought to determine risk factors for GVH
Autor:
Yang Yang, Usama Gergis, Matthew Carabasi, Joanne Filicko-O'Hara, John L. Wagner, William O'Hara, Adam Binder, Onder Alpdogan, Ubaldo Martinez-Outschoorn, Pierluigi Porcu, Neal Flomenberg, Dolores Grosso
Publikováno v:
Transplantation and cellular therapy. 28(3)
The 2-step graft engineering approach has been the main platform for allogeneic hematopoietic cell transplantation (allo-HCT) at Thomas Jefferson University since 2005. We have previously described separating donor lymphocyte infusion followed by cyc
Autor:
Miguel Pérez, Marjolein van der Poel, Vaibhav Agrawal, Mark R. Litzow, Partow Kebriaei, Khalid Bo-Subait, Nelli Bejanyan, John L. Wagner, Aric C. Hall, Jean A. Yared, A. Samer Al-Homsi, Gerhard C. Hildebrandt, Jan Cerny, Mohamed A. Kharfan-Dabaja, Brenda M. Sandmaier, Taiga Nishihori, O Ringdén, Amer Assal, Christopher G. Kanakry, Bipin N. Savani, Leo F. Verdonck, Amer Beitinjaneh, Marcos de Lima, Mitchell S. Cairo, Richard F. Olsson, Mary Lynn Savoie, Hillard M. Lazarus, Michael R. Grunwald, Michael Byrne, Natalie S. Callander, Leland Metheny, Christopher Bredeson, Jong Wook Lee, Sachiko Seo, Christopher S. Hourigan, Ulrike Bacher, Wael Saber, Mei-Jei Zhang, David A. Rizzieri, Vijaya Raj Bhatt, Shahrukh K. Hashmi, Yoshihiro Inamoto, Sunita Nathan, Daniel J. Weisdorf, Zachariah DeFilipp, Cesar O. Freytes, Hai-Lin Wang, Siddhartha Ganguly
Publikováno v:
Transplant Cell Ther
Transplantation and Cellular Therapy, 27(11). Elsevier
Transplantation and Cellular Therapy, 27(11). Elsevier
Patients who develop therapy-related myeloid neoplasm, either myelodysplastic syndrome (t-MDS) or acute myelogenous leukemia (t-AML), have a poor prognosis. An earlier Center for International Blood and Marrow Transplant Research (CIBMTR) analysis of
Autor:
John L. Wagner, Lindsay Wilde, Neil Palmisiano, Ubaldo E. Martinez-Outschoorn, Pierluigi Porcu, Gina Keiffer, Joanne Filicko-O'Hara, Dolores Grosso, Allison Zibelli, Matthew Carabasi, Neal Flomenberg, Michael Millenson, Onder Alpdogan, Thomas R. Klumpp, Usama Gergis, Amy R. MacKenzie, Adam Binder, Margaret Kasner
Publikováno v:
Blood
Introduction :The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and subsequent coronavirus-19 (COVID-19) pandemic has impacted hematologic malignancies (HM) care worldwide. Reported risk factors for severe COVID-19 pre